QHSLab (OTCQB:USAQ) Announces Launch of Q-Cog™ to Support Early Detection of Mild Cognitive Impairment and Dementia

3 weeks ago

Initial pilot of 168 patients aged 65 and older identifies 54% with high-risk cognitive scores; digital platform expands company’s value-based…

Ob Hospitalist Group Launches Commure’s Autonomous Coding to Support Clinicians and Strengthen Coding Accuracy

3 weeks ago

Autonomous Coding Reduces Administrative Burden and Gives Clinicians More Time to Focus on Patient CareMOUNTAIN VIEW, Calif., Dec. 03, 2025…

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

3 weeks ago

First Hydration Formula Powered by VINIA's Blood Flow Technology Enters the $13 Billion U.S. Electrolyte MarketVancouver, British Columbia and Rehovot,…

Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results

3 weeks ago

BEIJING, Dec. 3, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated…

S3 Connected Health Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Medical Device Connectivity

3 weeks ago

Recognized for pioneering advancements that redefine medical device connectivity, accelerate home-based care, and deliver transformative value across global healthcare ecosystems.SAN…

Bioz Stars Awards 2025: Honoring Global Leaders Driving the Future of Scientific Innovation

3 weeks ago

PALO ALTO, CALIFORNIA / ACCESS Newswire / December 3, 2025 / Bioz, Inc., the world's leading AI-powered platform for scientific…

President Trump Fixing DEA Marijuana Policy: Defies Logic, Law, and Science, Says MMJ International Holdings

3 weeks ago

MMJ International Holdings Exposes the Impossible Federal Catch-22 Blocking FDA Regulated Cannabis Medicine. "This is an equation with no solution.…

Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension

3 weeks ago

FDA scientific advice meeting provides guidance on planned Phase 3 study of radiodiagnostic lead candidate in treatment-resistant hypertension / primary…